Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Mason

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Radiography (London, England : 1995)|April 9, 2019
The volume of liver irradiated during modern free-breathing breast radiotherapy: Implications for theory and practiceN Courtier, T Gambling, P Barrett-Lee, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: design, synthesis and biological evaluationC Congiatu, C McGuigan, W G Jiang, et al.
The Cochrane Database of Systematic Reviews|October 21, 2006
Bisphosphonates for advanced prostate cancerK K Yuen, M Shelley, W M Sze, et al.
British Journal of Urology|March 1, 1990
Management of the contralateral testis in patients with testicular germ cell cancerM V Fordham, M D Mason, C Blackmore, et al.
Biochemical and Biophysical Research Communications|August 2, 2001
The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variantC Parr, G Davies, T Nakamura, et al.
Cancer Treatment Reviews|June 5, 2009
Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trialsM D Shelley, S Kumar, B Coles, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndromeN G Burnet, M D Mason, J A Hanson, et al.
Oncology Reports|December 6, 2005
The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cellsG M Harrison, G Davies, T A Martin, et al.
Cancer Treatment Reviews|October 18, 2008
A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinomaM D Shelley, S Kumar, T Wilt, et al.
International Journal of Oncology|October 9, 2002
Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interactionGregory M Harrison, G Davies, T A Martin, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Radiography (London, England : 1995)|April 9, 2019
The volume of liver irradiated during modern free-breathing breast radiotherapy: Implications for theory and practiceN Courtier, T Gambling, P Barrett-Lee, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: design, synthesis and biological evaluationC Congiatu, C McGuigan, W G Jiang, et al.
The Cochrane Database of Systematic Reviews|October 21, 2006
Bisphosphonates for advanced prostate cancerK K Yuen, M Shelley, W M Sze, et al.
British Journal of Urology|March 1, 1990
Management of the contralateral testis in patients with testicular germ cell cancerM V Fordham, M D Mason, C Blackmore, et al.
Biochemical and Biophysical Research Communications|August 2, 2001
The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variantC Parr, G Davies, T Nakamura, et al.
Cancer Treatment Reviews|June 5, 2009
Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trialsM D Shelley, S Kumar, B Coles, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndromeN G Burnet, M D Mason, J A Hanson, et al.
Oncology Reports|December 6, 2005
The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cellsG M Harrison, G Davies, T A Martin, et al.
Cancer Treatment Reviews|October 18, 2008
A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinomaM D Shelley, S Kumar, T Wilt, et al.
International Journal of Oncology|October 9, 2002
Distribution and expression of CD44 isoforms and Ezrin during prostate cancer-endothelium interactionGregory M Harrison, G Davies, T A Martin, et al.
Pageof 9